Optimizing the number of prostate biopsy (PB) cores in the initial diagnosis of prostate cancer is still an open question. Increasing the number of cores can expectedly lead to a higher cancer detection rate but more frequent, and greater number of adverse effects should be considered. It is necessary to limit the number of PBs, obtained from tumor areas and areas with a high suspect of malignancy. Simplified Prostate Imaging Reporting and Data System (PIRADS) using biparametric MR imaging (bpMRI) protocol identifies 4 categories indicating the management for each one. We suggest targeted biopsy for category 3b [lesion with a volume ≥0.5 cc, homogeneous or inhomogeneous, mild/moderately or markedly hypointense on T2-weighted, hyperintense on high b value diffusion-weighted (DW) imaging and moderately hypointense on apparent diffusion coefficient (ADC) map] and category 4 (homogeneous or heterogeneous lesion intra-or extraglandular, mild/moderately or markedly hypointense on T2-weighted, hyperintense on high b value DW imaging and markedly hypointense on ADC map). For a precise localization of the suspected prostate lesions we used a model of 41 sectors/regions map. BpMRI/Transrectal ultrasound fusion-targeted biopsy and the 41 sectors map represent a valid alternative model to the core biopsy of 10-12 systematic transrectal or transperineal peripheral zone biopsies.
In the initial diagnosis of prostate cancer (PCa), 10-12 systematic transrectal or transperineal peripheral zone core biopsies under ultrasound-guidance is recommended. [1] Although in the literature it is widely demonstrated that major complications might occur more frequently in the transrectal biopsy in comparison to transperineal biopsy [2] , the optimal number of prostate biopsy (PB) cores is still an open question. An increase in the number of cores can expectedly lead to a higher cancer detection rate, but the adverse effects (e.g. hematuria, rectal bleeding, hematospermia, urinary tract infection, acute urinary retention) are more frequent [3] and should be considered. As a consequence, it is necessary to limit the number of PBs taken from certain tumor areas or from areas with a high suspect of malignancy.
Tanaka et al. [4] performed PBs in 936 patients with suspect PCa. The Authors revealed that the cancer detection rate using the Nara Urological Research and Treatment Group (NURTG) nomogram allocating a number of 6-12 biopsy cores, based on age and prostate volume could lead to similar efficacy compared with previous studies performed with a greater number of biopsy cores. In older patients, the number of biopsy cores could be reduced and the incidence of adverse events ≥ grade 2 after PB were within acceptable levels.
In our experience to reduce the number of PB cores and complications in patients suspected of PCa, prior to biopsy, we perform biparametric MR imaging (bpMRI) protocol [including the T2-weighted and diffusion-weighted (DW) sequences with Apparent Diffusion Coefficient (ADC) maps reconstruction] at 3T without [5] , we introduced a model of 41 sectors/ regions map, adding a left and right segment of the median lobe into assessments (Figure 1 ). [6] Simplified PIRADS with bpMRI protocol identifies 4 categories indicating the management for each one. [7, 8] Based on our simplified PIRADS [7, 8] for bpMRI, targeted biopsy is indicated for category 3b (lesion with a volume ≥0.5 cc, homogeneous or inhomogeneous, mild/moderately or markedly hypointense on T2-weighted, hyperintense on high b value DW imaging and moderately hypointense on ADC map) and category 4 (homogeneous or heterogeneous lesion intra-or extraglandular, mild/ moderately or markedly hypointense on T2-weighted, hyperintense on high b value DW imaging and markedly hypointense on ADC map). We indicate no more than four lesions for each prostate and suggest obtaining four PB cores under transperineal route using bpMRI/Transrectal ultrasound fusion-targeted biopsy protocol.
In clinical practice, we suggest the use of bpMRI/Transrectal ultrasound fusion-targeted biopsy protocol and the 41 sectors map. It is a valid and alternative model to 10-12 systematic transrectal or transperineal core biopsies of the peripheral zone obtained under ultrasound imaging guidance that can reinforce the results of MRI/Transrectal ultrasound fusion-targeted biopsy while reducing its adverse effects. 
